獸醫眼科市場－全球產業規模、佔有率、趨勢、機會及預測（按類型、動物種類、給藥途徑、適應症、銷售管道、地區和競爭格局分類，2021-2031年）

全球獸醫眼科護理市場預計將從 2025 年的 52 億美元成長到 2031 年的 73.8 億美元，複合年成長率達到 6.01%。

此領域涵蓋動物眼科疾病治療中採用的診斷、藥物和手術方法。推動市場成長的關鍵因素包括眼部病患病率的上升和寵物飼養量的顯著成長，從而擴大了潛在患者群體。根據美國獸醫協會 (AVMA) 預測，到 2024 年，美國寵物犬的數量預計將達到 8,970 萬隻。這一成長趨勢與飼主日益重視寵物健康，進而導致相關服務需求不斷成長直接相關。

然而，由於專業眼科手術費用高昂且全球合格專業人員短缺，該領域面臨嚴峻挑戰。這些經濟和後勤方面的障礙可能會阻礙許多寵物飼主獲得所需的護理，並可能阻礙市場向新興經濟體的擴張。

市場促進因素

消費者在專業動物照護方面的支出不斷成長，是獸醫眼科護理產業發展的重要驅動力。隨著寵物飼主越來越將寵物視為家庭成員，他們為寵物支付包括眼科在內的先進醫療干預費用的意願也顯著提高。這種消費行為不僅限於基本的預防措施，還包括治療白內障、青光眼和視網膜退化等複雜疾病的先進療法。根據美國寵物用品協會2024年3月發布的數據，預計2023年美國寵物產業的總支出將達到1,474億美元。如此龐大的支出規模證明了飼主有能力負擔轉診獸醫服務，這也直接惠及致力於保護和恢復動物視力的專業診所。

寵物眼科治療保險覆蓋範圍的擴大，透過降低相關的經濟門檻，進一步加速了這些專業服務的普及。雖然複雜的眼科手術需要大量資金投入，但綜合保險的日益普及正在擴大這些必要治療的覆蓋範圍。例如，福布斯顧問公司2024年1月的報告指出，犬隻白內障手術的平均費用為每隻眼睛2,700美元至4,000美元，凸顯了恢復視力所需的巨額投資。因此，保險業正在迅速擴張，以應對這一潛在的經濟負擔。北美寵物健康保險協會（NAPHIA）2024年5月的報告顯示，美國寵物保險總保費預計將成長至39億美元，這標誌著經濟狀況正在向滿足高價值獸醫眼科護理需求的方向轉變。

市場挑戰

全球合格獸醫眼科專家的短缺是限制眼科市場擴張的一大瓶頸。動物眼科疾病通常需要複雜的手術介入和長期治療方案，而這些對於一般獸醫來說往往難以實現。如果合格獸醫眼科醫師的數量無法滿足不斷成長的寵物數量，就會立即且顯著地限制每年可進行的複雜手術數量，例如超音波超音波乳化術和角膜移植術。這種短缺導致患者等待時間過長，價格上漲，將部分消費者拒之門外，並限制了市場的總可實現收入。

人才短缺是一個結構性問題，直接限制了該行業的擴張能力，尤其是在服務不足的地區。目前新晉專家的數量不足以滿足快速成長的服務需求。根據美國獸醫學院協會的內部數據，到2024年，獸醫教師將出現10%的缺口，這一短缺直接阻礙了學術界培養下一代專家的能力。如果沒有足夠的新專業人員注入來緩解這種壓力，市場將難以擴展其服務範圍，導致已開發經濟體和新興經濟體都無法實現巨大的潛在收入。

市場趨勢

人工智慧 (AI) 在眼科疾病檢測領域的應用正在迅速且根本性地改變獸醫診療的診斷準確性和營運效率。這一趨勢引入了機器學習演算法，能夠分析複雜的視網膜影像和角膜掃描，從而識別青光眼、白內障和進行性視網膜萎縮等疾病，其準確率可與人類專家媲美。透過自動化評估眼部結構，這些工具減少了診斷錯誤，並使全科醫生能夠在將患者轉診給專科醫生之前更有效地進行眼科疾病的初步分診。這項技術變革的勢頭在專業人士的採納率上顯而易見。根據 2024 年 8 月發布的《北美獸醫界報告》，約 39.2% 的受訪獸醫專業人士在日常工作中使用人工智慧工具，這表明人工智慧驅動的眼科診斷技術擁有良好的發展前景，並有望繼續廣泛應用。

同時，持續眼部藥物傳輸技術正取得重要進展，以飼主在慢性眼科疾病管理中依從性差這一重大挑戰。傳統療法通常需要頻繁滴眼藥水，飼主難以堅持，且對於諸如角膜乾燥症等終身性疾病，往往療效不佳。新型生物工程水凝膠和鞏膜植入可透過在數週至數月內持續且可控制地釋放藥物，確保治療效果。鑑於某些犬種易患慢性眼表疾病，這項創新尤為重要。英國皇家獸醫學院2024年1月的研究發現，英國可卡犬罹患角膜乾燥症的機率是其他犬種的7.6倍，凸顯了市場對這些先進的長效治療方案的迫切需求。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球獸醫眼科市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 按類型（診斷、治療）
  • 依動物種類（狗、貓、馬、牛、其他）
  • 給藥途徑（口服、外用、注射）
  • 依適應症（眼瞼異常、白內障、青光眼、視網膜併發症、葡萄膜炎、結膜炎、角膜併發症、其他）
  • 銷售管道（獸醫診所、寵物專賣店、電子商務、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章 北美獸醫眼科市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲獸醫眼科市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區獸醫眼科市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲獸醫眼科市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲獸醫眼科市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球獸醫眼科市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Bausch+Lomb Corporation
• Akorn Operating Company LLC
• Boehringer Ingelheim International GmbH
• I-MED Pharma Inc.
• Innovacyn, Inc.
• Miracle Pet
• Compana Pet Brands LLC
• Zoetis Services LLC
• Epicur Pharma
• Icare Finland Oy

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Veterinary Eye Care Market is projected to expand from a valuation of USD 5.20 Billion in 2025 to USD 7.38 Billion by 2031, achieving a compound annual growth rate of 6.01%. This sector covers the diagnostic, pharmaceutical, and surgical approaches utilized to manage ocular diseases in animals. The primary factors driving market growth include the increasing prevalence of ophthalmic conditions combined with a measurable rise in pet ownership, which enlarges the potential patient base. According to the American Veterinary Medical Association, the population of pet dogs in the United States reached an estimated 89.7 million in 2024. This growing demographic correlates directly with heightened demand for services as owners place a higher priority on animal health.

However, the sector faces a substantial challenge regarding the high expense of specialized ophthalmic procedures and a global shortage of qualified specialists. These financial and logistical barriers can restrict access to necessary treatments for many pet owners and potentially hinder the broader expansion of the market into emerging economies.

Market Driver

Increasing consumer spending on specialized animal healthcare acts as a fundamental catalyst for the growth of the veterinary eye care sector. As pet owners increasingly view their companions as integral family members, their willingness to fund advanced medical interventions, including ophthalmology, has surged significantly. This economic behavior goes beyond basic preventative measures to include sophisticated treatments for complex conditions such as cataracts, glaucoma, and retinal degeneration. Data released by the American Pet Products Association in March 2024 indicated that total pet industry expenditures in the United States reached $147.4 billion in 2023. This substantial financial outlay demonstrates a robust economic capacity for owners to afford referral-based veterinary services, directly benefiting specialty practices focused on maintaining and restoring animal vision.

The expansion of pet insurance coverage for ophthalmic treatments further accelerates the adoption of these specialized services by mitigating associated financial barriers. Although complex ocular surgeries are capital-intensive, the rising penetration of comprehensive insurance policies allows for broader access to these necessary procedures. For instance, Forbes Advisor noted in January 2024 that the average cost of cataract surgery for dogs ranges between $2,700 and $4,000 per eye, highlighting the significant investment required for restorative vision care. Consequently, the insurance sector has expanded rapidly to address these potential liabilities; the North American Pet Health Insurance Association reported in May 2024 that total pet insurance premiums in the United States increased to $3.9 billion, signaling a shift toward financial preparedness that sustains the demand for high-value veterinary eye care.

Market Challenge

The global shortage of qualified veterinary specialists represents a critical bottleneck that effectively restrains the expansion of the eye care market. Ocular diseases in animals often require sophisticated surgical interventions and long-term management plans that general practitioners are rarely equipped to provide. When the supply of board-certified veterinary ophthalmologists fails to keep pace with the increasing population of pets, the immediate result is a severe limitation on the number of advanced procedures, such as phacoemulsification or corneal grafts, that can be performed annually. This scarcity creates long wait times and forces price increases that inevitably price out a segment of the consumer base, thereby capping the market's total realizable revenue.

This workforce deficit is structural and directly restricts the industry's capacity to scale operations, particularly in underserved regions. The pipeline for new specialists is currently insufficient to meet the surging demand for services. According to internal data from the American Association of Veterinary Medical Colleges in 2024, there is a 10% shortage of veterinary faculty, a deficit that directly impedes the academic sector's ability to train and graduate the next generation of specialists. Without a robust influx of new professionals to alleviate this pressure, the market struggles to broaden its service reach, leaving significant potential revenue in both developed and emerging economies unrealized.

Market Trends

The integration of Artificial Intelligence for ocular disease detection is rapidly and fundamentally altering diagnostic precision and workflow efficiency within veterinary practices. This trend involves the deployment of machine learning algorithms capable of analyzing complex retinal images and corneal scans to identify pathologies such as glaucoma, cataracts, and progressive retinal atrophy with accuracy comparable to human specialists. By automating the assessment of ocular structures, these tools reduce diagnostic errors and allow general practitioners to triage eye conditions more effectively before referring to specialists. The momentum of this technological shift is evident in professional adoption rates; according to the North American Veterinary Community's August 2024 report, approximately 39.2% of surveyed veterinary industry experts now utilize AI tools in their daily work, signaling a robust environment for the continued penetration of AI-driven ophthalmic diagnostics.

Simultaneously, the market is witnessing a critical advancement in sustained-release ocular therapeutic delivery designed to overcome the significant challenge of owner compliance in managing chronic eye conditions. Conventional treatment often requires frequent administration of eye drops, which is difficult for pet owners to maintain consistently, leading to suboptimal clinical outcomes for lifelong diseases like keratoconjunctivitis sicca. New bio-engineered hydrogels and episcleral implants allow for the continuous, controlled release of medication over weeks or months, ensuring therapeutic efficacy. This innovation is particularly vital given the high susceptibility of certain breeds to chronic ocular surface diseases; a January 2024 study by the Royal Veterinary College highlighted that English Cocker Spaniels exhibit a 7.6 times higher risk of developing keratoconjunctivitis sicca compared to other breeds, underscoring the urgent market need for these advanced, long-acting therapeutic solutions.

Key Market Players

• Bausch + Lomb Corporation
• Akorn Operating Company LLC
• Boehringer Ingelheim International GmbH
• I-MED Pharma Inc.
• Innovacyn, Inc.
• Miracle Pet
• Compana Pet Brands LLC
• Zoetis Services LLC
• Epicur Pharma
• Icare Finland Oy

Report Scope

In this report, the Global Veterinary Eye Care Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Eye Care Market, By Type

• Diagnosis
• Treatment

Veterinary Eye Care Market, By Animal Type

• Canine
• Feline
• Equine
• Bovine
• Other

Veterinary Eye Care Market, By Route of Administration

• Oral
• Topical
• Injectable

Veterinary Eye Care Market, By Indication

• Eyelid Abnormalities
• Cataract
• Glaucoma
• Retinal Complications
• Uveitis
• Conjunctivitis
• Corneal Complications
• Others

Veterinary Eye Care Market, By Sales Channel

• Veterinary Hospitals & Clinics
• Pet Specialty Stores
• E-Commerce
• Others

Veterinary Eye Care Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Eye Care Market.

Available Customizations:

Global Veterinary Eye Care Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Eye Care Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Diagnosis, Treatment)
  • 5.2.2. By Animal Type (Canine, Feline, Equine, Bovine, Other)
  • 5.2.3. By Route of Administration (Oral, Topical, Injectable)
  • 5.2.4. By Indication (Eyelid Abnormalities, Cataract, Glaucoma, Retinal Complications, Uveitis, Conjunctivitis, Corneal Complications, Others)
  • 5.2.5. By Sales Channel (Veterinary Hospitals & Clinics, Pet Specialty Stores, E-Commerce, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Veterinary Eye Care Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Animal Type
  • 6.2.3. By Route of Administration
  • 6.2.4. By Indication
  • 6.2.5. By Sales Channel
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Veterinary Eye Care Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Animal Type
      • 6.3.1.2.3. By Route of Administration
      • 6.3.1.2.4. By Indication
      • 6.3.1.2.5. By Sales Channel
  • 6.3.2. Canada Veterinary Eye Care Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Animal Type
      • 6.3.2.2.3. By Route of Administration
      • 6.3.2.2.4. By Indication
      • 6.3.2.2.5. By Sales Channel
  • 6.3.3. Mexico Veterinary Eye Care Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Animal Type
      • 6.3.3.2.3. By Route of Administration
      • 6.3.3.2.4. By Indication
      • 6.3.3.2.5. By Sales Channel

7. Europe Veterinary Eye Care Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Animal Type
  • 7.2.3. By Route of Administration
  • 7.2.4. By Indication
  • 7.2.5. By Sales Channel
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Veterinary Eye Care Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Animal Type
      • 7.3.1.2.3. By Route of Administration
      • 7.3.1.2.4. By Indication
      • 7.3.1.2.5. By Sales Channel
  • 7.3.2. France Veterinary Eye Care Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Animal Type
      • 7.3.2.2.3. By Route of Administration
      • 7.3.2.2.4. By Indication
      • 7.3.2.2.5. By Sales Channel
  • 7.3.3. United Kingdom Veterinary Eye Care Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Animal Type
      • 7.3.3.2.3. By Route of Administration
      • 7.3.3.2.4. By Indication
      • 7.3.3.2.5. By Sales Channel
  • 7.3.4. Italy Veterinary Eye Care Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Animal Type
      • 7.3.4.2.3. By Route of Administration
      • 7.3.4.2.4. By Indication
      • 7.3.4.2.5. By Sales Channel
  • 7.3.5. Spain Veterinary Eye Care Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Animal Type
      • 7.3.5.2.3. By Route of Administration
      • 7.3.5.2.4. By Indication
      • 7.3.5.2.5. By Sales Channel

8. Asia Pacific Veterinary Eye Care Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Animal Type
  • 8.2.3. By Route of Administration
  • 8.2.4. By Indication
  • 8.2.5. By Sales Channel
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Veterinary Eye Care Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Animal Type
      • 8.3.1.2.3. By Route of Administration
      • 8.3.1.2.4. By Indication
      • 8.3.1.2.5. By Sales Channel
  • 8.3.2. India Veterinary Eye Care Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Animal Type
      • 8.3.2.2.3. By Route of Administration
      • 8.3.2.2.4. By Indication
      • 8.3.2.2.5. By Sales Channel
  • 8.3.3. Japan Veterinary Eye Care Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Animal Type
      • 8.3.3.2.3. By Route of Administration
      • 8.3.3.2.4. By Indication
      • 8.3.3.2.5. By Sales Channel
  • 8.3.4. South Korea Veterinary Eye Care Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Animal Type
      • 8.3.4.2.3. By Route of Administration
      • 8.3.4.2.4. By Indication
      • 8.3.4.2.5. By Sales Channel
  • 8.3.5. Australia Veterinary Eye Care Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Animal Type
      • 8.3.5.2.3. By Route of Administration
      • 8.3.5.2.4. By Indication
      • 8.3.5.2.5. By Sales Channel

9. Middle East & Africa Veterinary Eye Care Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Animal Type
  • 9.2.3. By Route of Administration
  • 9.2.4. By Indication
  • 9.2.5. By Sales Channel
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Veterinary Eye Care Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Animal Type
      • 9.3.1.2.3. By Route of Administration
      • 9.3.1.2.4. By Indication
      • 9.3.1.2.5. By Sales Channel
  • 9.3.2. UAE Veterinary Eye Care Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Animal Type
      • 9.3.2.2.3. By Route of Administration
      • 9.3.2.2.4. By Indication
      • 9.3.2.2.5. By Sales Channel
  • 9.3.3. South Africa Veterinary Eye Care Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Animal Type
      • 9.3.3.2.3. By Route of Administration
      • 9.3.3.2.4. By Indication
      • 9.3.3.2.5. By Sales Channel

10. South America Veterinary Eye Care Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Animal Type
  • 10.2.3. By Route of Administration
  • 10.2.4. By Indication
  • 10.2.5. By Sales Channel
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Veterinary Eye Care Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Animal Type
      • 10.3.1.2.3. By Route of Administration
      • 10.3.1.2.4. By Indication
      • 10.3.1.2.5. By Sales Channel
  • 10.3.2. Colombia Veterinary Eye Care Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Animal Type
      • 10.3.2.2.3. By Route of Administration
      • 10.3.2.2.4. By Indication
      • 10.3.2.2.5. By Sales Channel
  • 10.3.3. Argentina Veterinary Eye Care Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Animal Type
      • 10.3.3.2.3. By Route of Administration
      • 10.3.3.2.4. By Indication
      • 10.3.3.2.5. By Sales Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Veterinary Eye Care Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Bausch + Lomb Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Akorn Operating Company LLC
• 15.3. Boehringer Ingelheim International GmbH
• 15.4. I-MED Pharma Inc.
• 15.5. Innovacyn, Inc.
• 15.6. Miracle Pet
• 15.7. Compana Pet Brands LLC
• 15.8. Zoetis Services LLC
• 15.9. Epicur Pharma
• 15.10. Icare Finland Oy

16. Strategic Recommendations

17. About Us & Disclaimer